Addressing False Positivity in Lung Cancer Screening

August 20, 2014 3:51 pm
0 Comments comment
Addressing False Positivity in Lung Cancer Screening

One out of four individuals at high risk of lung cancer who receive a low-dose CT scan as part of the lung cancer screening process will have a spot on their lung. Of those patients, 96.3 percent will be found to not have cancer. In many cases, the only way to confirm whether a spot is cancerous is an invasive procedure that can be expensive and stressful while possibly...
Read More

There is No Routine Prostate Cancer

August 12, 2014 1:16 pm
0 Comments comment
There is No Routine Prostate Cancer

At The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James), we understand that there is no such thing as routine prostate cancer. The OSUCCC – James brings together experts from a variety of disciplines to detect, diagnose and analyze your prostate cancer at the genetic level. “Traditionally, we diagnose … prostate cancer by examining the way cells appear under a...
Read More

Pelotonia-Supported Genomic Sequencing Provides Targeted Cancer Therapies

August 5, 2014 7:10 am
0 Comments comment
Pelotonia-Supported Genomic Sequencing Provides Targeted Cancer Therapies

Jared Gordon thought he had a bad cold. But after he couldn’t kick the sickness for a month, he went to the doctor for tests that revealed the true source of his prolonged illness: stage 4 lung cancer. The tumor had spread to the lining of his lungs and surrounding lymph nodes. The 51-year-old single father of three was told he had six months to live. But Gordon decided...
Read More

Pelotonia-Supported Clinical Trial Returns Patient to Active Lifestyle

July 22, 2014 8:06 am
0 Comments comment
Pelotonia-Supported Clinical Trial Returns Patient to Active Lifestyle

Wally Yocum, a technical manager at the Marietta branch of Koroseal Interior Products, LLC, has a biology degree from Fairleigh-Dickinson University in New Jersey that he pursued partly because he thought, “Maybe I could help find a cure for something.” Years later, he did just that by participating in clinical trials for patients with chronic lymphocytic leukemia (CLL) at The Ohio State University Comprehensive Cancer Center – James Cancer...
Read More